Zhai X - Search Results

1

OFCC1-ALK (Ointergenic: A20): A novel OFCC1 intergenic region-ALK fusion identified from a lung adenocarcinoma patient.

Zhai X, Wu Q, Zeng Z, Suo J, Lin F, Zhou Q. Zhai X, et al. Lung Cancer. 2021 Mar;153:171-173. doi: 10.1016/j.lungcan.2020.12.034. Epub 2021 Jan 11. Lung Cancer. 2021. PMID: 33483163 No abstract available.

2

The truncated Rv2820c of Mycobacterium tuberculosis Beijing family augments intracellular survival of M. smegmatis by altering cytokine profile and inhibiting NO generation.

Zhai X, Luo T, Peng X, Ma P, Wang C, Zhang C, Suo J, Bao L. Zhai X, et al. Infect Genet Evol. 2018 Apr;59:75-83. doi: 10.1016/j.meegid.2018.01.027. Epub 2018 Jan 31. Infect Genet Evol. 2018. PMID: 29407192

3

PPE11 of Mycobacterium tuberculosis can alter host inflammatory response and trigger cell death.

Peng X, Luo T, Zhai X, Zhang C, Suo J, Ma P, Wang C, Bao L. Peng X, et al. Among authors: zhai x. Microb Pathog. 2019 Jan;126:45-55. doi: 10.1016/j.micpath.2018.10.031. Epub 2018 Oct 23. Microb Pathog. 2019. PMID: 30366125

4

[Mycobacterium Tuberculosis Rv3084 Encodes Functional Esterase and Suppresses the Pro-inflammatory Cytokines in vivo].

Zhang CX, Luo T, Ma PJ, Wang CH, Suo J, Zhai XQ, Peng X, Bao L. Zhang CX, et al. Among authors: zhai xq. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 May;50(3):291-297. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31631592 Chinese.

5

Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy.

Zhai X, Wu Q, Pu D, Yin L, Wang W, Zhu D, Xu F. Zhai X, et al. Front Oncol. 2022 Jan 5;11:782682. doi: 10.3389/fonc.2021.782682. eCollection 2021. Front Oncol. 2022. PMID: 35070986 Free PMC article.

6

Demographics, clinical features, and prognosis of rare lymphoepithelioma-like carcinoma across different anatomic sites.

Zhai X, Liu J, Lu D, Zhou Q. Zhai X, et al. J Egypt Natl Canc Inst. 2022 Feb 1;34(1):5. doi: 10.1186/s43046-021-00103-2. J Egypt Natl Canc Inst. 2022. PMID: 35102459

7

Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis.

Yin L, Zhang W, Pu D, Zhai X, Lin Y, Wu Q, Chang T, Hu J, Li Y, Zhou Q. Yin L, et al. Among authors: zhai x. Front Oncol. 2022 Feb 2;11:778549. doi: 10.3389/fonc.2021.778549. eCollection 2021. Front Oncol. 2022. PMID: 35186710 Free PMC article.

8

Combination of STING agonist and CXCR3 antagonist disrupts immune tolerance to overcome anti-PD-L1 resistance in lung adenocarcinoma under oxidative stress.

Zhu L, Gao H, Huang S, Cao T, Zhai X, Hu J, Wang T, Dong J, Liu Z, Chen J, Liu J, Zhang Z, Zhou Q. Zhu L, et al. Among authors: zhai x. Gene. 2023 Jan 30;851:146962. doi: 10.1016/j.gene.2022.146962. Epub 2022 Oct 19. Gene. 2023. PMID: 36272651

9

The shadows hang over immunotherapy-neutrophil extracellular traps in cancer.

Pu D, Yin L, Zhai X, Wang R, Huang L, Wu Q, Zhu L, Zhou Y, Zhou Q, Li L. Pu D, et al. Among authors: zhai x. Sci China Life Sci. 2023 May;66(5):1196-1199. doi: 10.1007/s11427-022-2243-4. Epub 2022 Dec 23. Sci China Life Sci. 2023. PMID: 36580164 No abstract available.

10

Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib.

Zhai X, Wang T, Lin Y, Zhang J, Wang Y, Wang W, Zhou Q, Zhu D. Zhai X, et al. Front Oncol. 2023 Mar 29;13:1104910. doi: 10.3389/fonc.2023.1104910. eCollection 2023. Front Oncol. 2023. PMID: 37064118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,864 results

Search Page

Filters